Newsroom

 

Kiadis Pharma announces collaboration with the Julius Maximilians University of Würzburg, Germany. Dr. Mielke continues his collaboration with Kiadis Pharma on ATIR™ May 29th 2008
Biopharmaceutical company Kiadis Pharma announces today the clinical development collaboration for its lead product ATIR™ with Dr. Stephan Mielke and... read more    (NL version)


Kiadis Pharma receives Orphan Drug Designation for Rhitol™ from the FDA Apr 15th 2008
Biopharmaceutical company Kiadis Pharma announced today that the U.S. Food and Drug Administration (FDA) has granted its product Rhitol™ Orphan Drug... read more    (NL version)


Promising clinical data from Kiadis Pharma’s lead product ATIR™ presented by NIH investigators Mar 25th 2008
Biopharmaceutical company Kiadis Pharma announces the presentation of results obtained so far in a physician initiated clinical study for ATIR™ led... read more    (NL version)



Kiadis home  Kiadis Pharma Press Releases

Kiadis Pharma Press Releases are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader.


Kiadis Pharma - News

Feb 22nd 2008

Jan 31st 2008

Dec 19th 2007

Dec 14th 2007

Nov 28th 2007

Nov 23rd 2007

Nov 19th 2007

Nov 7th 2007

Oct 10th 2007

Aug 31st 2007

Aug 17th 2007

Jul 21st 2007

Jul 9th 2007

Jun 26th 2007

Mar 28th 2007

Feb 12th 2007

Jan 19th 2007

Dec 13th 2006

Dec 12th 2006

Dec 11th 2006

Nov 28th 2006






 




Kruislaan 419 (Matrix I)
1098 VA  Amsterdam
The Netherlands
t   +31 (0)20 888 48 15
f   +31 (0)20 888 48 63

Zernikepark 6-8
9747 AN  Groningen
The Netherlands
t   +31 (0) 50 547 42 70
f   +31 (0) 50 547 42 71

2525 ave. Marie-Curie
Saint-Laurent (Quebec)
Canada H4S 2E1
t   +1 (514) 336-4886
f   +1 (514) 336-7329